Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 40.60
+0.30 (0.74%)
Jul 18, 2025, 1:30 PM CST
Pharmosa Biopharm Company Description
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan.
It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease.
The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016.
Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.
Pharmosa Biopharm Inc.
| Country | Taiwan |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Pei Kan |
Contact Details
Address: No. 508, Sec. 7, Zhongxiao E. Rd. Taipei City Taiwan | |
| Phone | 886 2 2782 7561 |
| Website | pharmosa.com.tw |
Stock Details
| Ticker Symbol | 6875 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006875008 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Pei Kan Ph.D. | President, GM and Director |
| Shu-Ping Yang | Vice President of Finance and Accounting |
| Hui-An Pao | Vice President of Operations |
| Ru-Yun Lin M.B.A. | Vice President of Administration |